Article
The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice.
Biochimica et biophysica acta. Molecular basis of disease - 1 Jul 2021
Dekeryte Ruta, Franklin Zara, Hull Claire, Croce Lorenzo, Kamli-Salino Sarah, Helk Oliver, Hoffmann Philip A, Yang Zhixiang, Riedel Gernot, Delibegovic Mirela, Platt Bettina
Abstract excerpt
AIM: The β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) has been identified as the central initiator of amyloid β (Aβ) generation in the brain, the key hallmark of Alzheimer's disease (AD). However, recent studies provided evidence that BACE1 also plays a crucial role in metabolic regulation, and we have shown that neuronal human BACE1 knock-in mice (PLB4) display type 2 diabetes mellitus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
